why is tirzepatide being taken off the market FDA Says Compounded Must Exit The Impact of New FDA

If this happens, stop the medication and seek medical care promptly

When comparing effectiveness, the Wegovy injection is generally considered significantly more effective for weight loss than oral alternatives

Safety Profile in Research Contexts Gastrointestinal events (nausea, vomiting, diarrhea, constipation) remain the most common adverse effects, typically mild to moderate, dose-dependent, and often mitigated by gradual dose escalation starting at lower levels (e.g., 2 mg)

Notably, the introduction of a PTA ligand in 6b dramatically impairs the ability of the compound to inhibit GST P1-1

Dalton TP, Chen Y, Schneider SN, Nebert DW, Shertzer HG